{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:03:28Z","timestamp":1786993408413,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jsat.2008.09.001","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T07:40:19Z","timestamp":1226475619000},"page":"428-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting"],"prefix":"10.1016","volume":"36","author":[{"given":"Abigail C.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L.","family":"Catz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Mona","family":"Deprey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Zbikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2008.09.001_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Statistical Methodology)"},{"key":"10.1016\/j.jsat.2008.09.001_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2008.09.001_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: Valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.jsat.2008.09.001_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2008.09.001_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/pr.55.3.6","article-title":"PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2)","volume":"55","author":"Leabman","year":"2003","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.jsat.2008.09.001_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1037\/1064-1297.15.1.21","article-title":"Gender differences in acute tobacco withdrawal: Effects on subjective, cognitive, and physiological measures","volume":"15","author":"Leventhal","year":"2007","journal-title":"Experimental & Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2008.09.001_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2008.09.001_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2008.09.001_bib9","series-title":"Chantix (varenicline) Tablets","author":"Pfizer Labs","year":"2006"},{"key":"10.1016\/j.jsat.2008.09.001_bib10","series-title":"SAS 9.1 help and documentation","author":"SAS Institute Inc.","year":"2002"},{"key":"10.1016\/j.jsat.2008.09.001_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/jwh.2006.0281","article-title":"Treating tobacco dependence in women","volume":"16","author":"Schnoll","year":"2007","journal-title":"Journal of Women's Health"},{"key":"10.1016\/j.jsat.2008.09.001_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14622200701239662","article-title":"Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit","volume":"9","author":"Toll","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.jsat.2008.09.001_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1037\/0022-006X.67.4.555","article-title":"Gender differences in smoking cessation","volume":"67","author":"Wetter","year":"1999","journal-title":"Journal of Consulting & Clinical Psychology"},{"key":"10.1016\/j.jsat.2008.09.001_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1185\/030079907X182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Current Medical Research and Opinion"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547208001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547208001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:32:48Z","timestamp":1760038368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547208001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0740547208001499"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2008.09.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2008.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}